Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
BIBLIOGRAPHY
Peer Reviewed Papers
Books
Chapter in Books
Editorial Activities
STEFANO PALLANTI MD. PhD
PEER REVIEWED PAPERS (excluding papers in Italian)
Uzunova G, Pallanti S, Hollander E. Excitatory/inhibitory imbalance in autism spectrum disorder:
Implications for interventions and therapeutics. World J. Biol Psychiatry. 2015 Oct 15:1-13. [Epub ahead of
print] PMID: 26469219
Dell'Osso B, Nicolini H, Lanzagorta N, Benatti B, Spagnolin G, Palazzo MC, Marazziti D, Hollander E,
Fineberg N, Stein DJ, Pallanti S, Van Ameringen M, Lochner C, Hranov N, Karamustafalioglu O, Hranov L,
Zohar J, Denys d, Altamura AC, Menchon JM. Cigarette smoking in patients with obsessive compulsive
disorder: a report from International College of Obsessive Compulsive Spectrum Disorder (ICOCS). CNS
Spectr. 2015 oct; 20(5):469-73. doi: 10.1017/S1092852915000565. Epub 2015 Sep 9. PMID: 26349811.
Pallanti S, Salerno L. Raising attention to attention deficit hyperactivity disorder in schizophrenia. World J
Psychiatry. 2015 Mar22;5(1):47-55. Doi:10.5498/wjp.v5.i1.47 PMID: 25815254.
Galderisi S, Rossi A, Rocca P, Bertolino A, Mucci A, Bucci P, Rucci P, Gibertoni D, Aguglia E, Amore M,
Bellomo A, Biondi M, Brugnoli R, Dell'Osso L, De Ronchi D, Di Emidio G, Di Giannantonio M, Fagiolini a,
Marchesi C, Monteleone P, Oldani L, Pinna F, Roncone R, Sacchetti E, Santonastaso P, Siracusano A, Vita A,
Zeppegno P, Maj M; Italian Network for Research on Psychoses. The influence of illness-related variables,
personal resources and context-related factors on real-life functioning of people with schizophrenia. World
Psych. 2014 Oct; 13(3):275-87.doi:10.1002/wps.20167. PMID: 25273301 [Pubmed]
*Collaborator: Pallanti S.
Grassi G, Godini L, Grippo A, Piccagliani D, Pallanti S. Enhancing Cognitive-behavioral Therapy with
Repetitive Transcranial Magnetic Stimulation in Refractory Obsessive-Compulsive-Disorder: a Case Report.
Brain Stimul.2014.10.18 PMID:25456982. [ PubMed – as supplied by publisher ]
Mucci A, Rucci P, Rocca P, Bucci P, Gibertoni D, Merlotti E, Galderisi S, Maj M; Italian Network for
Research on Psychoses. Schizophr. Res. 2014 Oct; 159(1):144-50. doi: 10.1016/j.schres.2014.07.044. Epub
2014 Aug 30. PMID: 25182540 [Pubmed-in process]
1
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
* Collaborator: Pallanti S.
Pallanti S, Grassi G. Pharmacologic treatment of obsessive-compulsive disorder comorbidity. Expert Opin
Pharmacother. 2014.12.15;15(17):2543-52.Epub 2014 Sep 25. PMID:25252717 [ PubMed – in process ]
Lochner C, Fineberg NA, Zohar J, Van Ameringen M, Juven_Wetzler A, Altamura AC Cuzen NL, Hollander
E, Denys D, Nicolini H, Dell'Osso B, pallanti S, Stein DJ, Comorbidity in obsessive-compulsive disorder
(OCD): a report from the International College of Obsessive-Compulsive Spectrum Disorder (ICOCS).
Compr Psychiatry. 2014 Oct;55(7):1513-9. Epub 2014 Jun 9. PMID:25011690 .
Pallanti S, Tofani T, Zanardelli M, Di Cesare mannelli L, Ghelardini C. BDNF and ARTEMIN are increased
in drug-naive non-depressed GAD patients: preliminary data. Int J Psychiatry Clin Pract. 2014 Oct;
18(4):255-60. Epub 2014 aug 12. PMID: 24994477 [ PubMed – in process ]
Aguglia E, Biggio G, Signorelli MS, Mencacci C; Steering Committee on behalf of the STIMA-D
Investigators. Pharmacopsychiatry.2014 May;47(3). Epub 2014 May 20. PMID 24846085 [ PubMed – in
process ]
* Collaborator: Pallanti S.
Pallanti S, Grassi G, Ramella Cravaro V, Goodman W.K. From Psychopathology to neurocircuits: what we
can learn from DBS? The case of obsessive-compulsive disorder. J. Psychopathol. 2014;20:27-32
Pallanti S, Bernardi S, Antonini S, Singh N, Hollander E. ondasetron augmentation in patients with
obsessive-compulsive disorder who are inadequate responders to serotonin reuptake inhibitors: improvement
with treatment and worsening following discontinuation. Eur Neuropsychopharmacol. 2014 Mar; 24(3):375380. Doi: 10.1016/j.euroneuro.2013.12.003. Epub 2013 dec.11. PMID: 24406025 [ PubMed – in process ]
Pallanti S, Grassi G, Antonini S, Quercioli L, Salvadori E, Hollander E. rTMS in resistant mixed states: An
exploratory study. J Affect Disord. 2014 Mar 20; 157:66-71. Doi:10.1016/j.jad. 2013.12.024. Epub Dec 28.
PMID: 24581830 [ PubMed – in process ]
Pallanti S, Grassi G, Cantisani A. Emerging drugs to treat aobsessive-compulsive disorders. Expert opin
Emerg Drugs, 2014 Mar; 19(1):66-77. Doi:10.1016/j.euroneuro.2013.12.003. Epub 2013 Dec 31. PMID:
24377420 [ PubMed – in process ]
Di Rubbo, R., Sogaro, E., & Pallanti, S. (2013). Communicative Evolutive Psychotherapy Adapted
for
the Psychodynamic Group Setting in the Treatment of Pathological Interpersonal Dynamics of Identity /
Summary / Zusammenfassung (Simone Lipka, Berlin). Dynamische Psychiatrie, 46(3),
p. 204/222/226.
Van Ameringen S, Simpson W, Patterson B, Dell’Osso B, Finebg n, Hollander E, Hranov L, Hranov G,
Lochner C, Karamustafalioglu O, Marazziti D, Menchon JM, Nicolini H, Pallanti S, Stein DJ, Zohar J.
Pharmachological treatment strategies in obsessive-compulsive disorder: A cross-sectional view in nine
international OCD centers. J Psychopharmacol 2014 Jan 15 [ Epub ahead of print]. PMID: 24429223
[ PubMed – as supplied by publisher ]
2
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
Carelli R, Pallanti S. Streptococcal infections of skin and PANDAS. Dermatol. Ther. 2014 Jan; 27(1):28-30.
Doi: 10.1111/dth.12037. Epub 2013 Apr 1. PMID: 24502308 [ PubMed – in process ]
Marras A, Pallanti S. Transcranial magnetic stimulation fo the treatment of pharmacoresistant nondelusional
auditory verbal allucinations in dementia. Case Rep Psychiatry. 2013; 2013:930304. Doi:
10.1155/2013/930304. Epub 2013 Oct 2. PMID: 24198993 [PubMed]
Grassi G, Poli L, Cantisani A, Righi L, Ferrari G, Pallanti S. Hypocondriasis and obsessive-compulsive
disorder in schizophrenic patients treated with clozapine vs other atipica antipsychotics. CNS Spectr. 2013
Nov 1: 1-7 [Epub ahead of print]. PMID: 24176043 [PubMed – as supplied by publisher]
Pallanti S, Hollander E. Pharmacological, experimental therapeutic, and transcranial magnetic stimulation
treatments for compulsivity and impulsivity. CNS Spectr. 2013 Nov1: 1-12 [Epub ahead of print]. PMID:
24176028 [PubMed – as supplied by publisher]
Pallanti S, Grassi G, Tofani T, Spitoni S. Pharmacological Treatments for Behavioral Addictions: From
Behavioral Dimensions to the Research Domain Criteria Based Target. Psychopharmacology, Volume 2,
Number 3, Aug 2013, pp. 183-189(7)
Dell’Osso B, Benatti B, Buoli M, Altamura AC, Marazziti D, Hollander E, Fineberg N, Stein DJ, Pallanti S,
Nicolini H, Van Ameringen M, Lochner C, Hranov G, Karamustafalioglu O, Hranov L, Menchon JM, Zohar
J; ICOCS group. The influence of age at onset and duration of illness on long-term outcome in patients with
obsessive-compulsive disorder, a report from the International College of Obsessive Compulsive Spectrum
Disorders
(ICOCS).
Eur
Neuropsychopharmacol.
2013
Aug;
23(8):86571.doi:10.1016/j.euroneuro.2013.05.004.Epub 2013 Jun 21. PMID: 23791024 [PubMed – in process]
Pallanti S, Cantisani A, Grassi G. Anxiety as a core aspect of schizophrenia. Curr Psychiatry Rep. 2013
May; 15(5):354.doi:10.1007/s 11920-013-0354-7. PMID: 23532444 [PubMed – indexed for MEDLINE]
Carelli R., Pallanti S. Steptococcal infections of skin and PANDAS. Dermatologic Therapy. 01-05-2013.
Berlin HA, Braun A, Simeon D, Koran LM, Potenza MN, McElroy SL, Fong T, Pallanti S, Hollander E. A
double-blind, placebo-controlled trial of topiramate for pathological gambling. World J Biol Psychiatry. 2013
Mar 14 (2): 121-128 PubMed PMID: 21486110.
Valenti R, Salvadori E, Pescini F, Poggesi A, Castellini G, Antonini S, Bianchi S, Inzitari D, Pallanti S,
Pantoni L., Facial Affect Recognition in CADASIL Patients., Arch Clin Neuropsychol. 2013 Feb;28(1):6571. doi: 10.1093/arclin/acs097. Epub 2012 Nov 4., PMID: 23127883 [PubMed - in process]
Baldwin DS, Pallanti S, Zwanzger P. Developing a European Research Network to Address Unmet Needs in
Anxiety Disorders. Neurosci Biobehav Rev. 2013 Jan 10. doi:pii: S0149-7634(13)00010-9.
10.1016/j.neubiorev.2013.01.09. [Epub ahead of print], PMID: 23313646 [PubMed - as supplied by
publisher]
3
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
Pallanti S., Comprehensive care of schizophrenia: a textbook of clinical management, 2nd edition. Am J
Psychiatry. 2013 Jan 1;170(1):125-6. doi: 10.1176/appi.ajp.2012.12070936. No abstract available. PMID:
23288391 [PubMed - in process]
Bandinelli F, Prignano F, Bonciani D, Pallanti S, Lotti T, Salaffi F, Bartoli F, Candelieri A, Giovannini L,
Maddali Bongi S, Matucci-Cerinic M. Clinical and demographic factors influence on anxiety and depression
in early psoriatic arthritis (ePsA). Clin Exp Rheumatol. 2012 Dec 6. [Epub ahead of print], PMID: 23295140
[PubMed - as supplied by publisher]
Pallanti S., Grassi G., Cantisani A. Treatment Resistance. Ossessive Compulsive Disorder: Current Science
and Clinical Practice, Pag. 1976, 2012-08-13.
Moretti S., Arunachalam M., Colucci R., Pallanti S., Kline JA., Berti S., Lotti F., Lotti T. Autoimmune
markers in vitiligo patients appear correlated with obsession and phobia. Journal of the European Academy
of Dermatology and Venereology 26 (7), 861-867, 2012-07-01.
S. Pallanti, A. Di Rollo, S. Antonini, E. Hollander and L.Quercioli Low Frequency rTMS over Right
Dorsolateral Prefrontal Cortex in the Treatment of Resistant Depression: Cognitive Improvement is
Independent from Clinical Response, Neuropsychobiology 2012 Jun; 65(4):227-35. Doi:10.1159/000336999
Pallanti S., Grassi G., Cantisani A. Approaches to treatment resi stance. Obsessive Compulsive Disorder:
Current Science and Practice. Chichester, Wiley-Blackwell, 99-131, 2012-05-31
Pallanti S, Cantisani A, Grassi G, Antonini S, Cecchelli C, Burian J, Cauli G, Quercioli L. rTMS agedependent response in treatment resistant depressed subjects: a mini-review, CNS Spectrums (2012), 17, 2430, & Cambridge University Press 2012
Valenti R, Pescini F, Antonini S, Castellini G, Poggesi A, Bianchi S, Inzitari D, Pallanti S, Pantoni L. Major
depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview. Acta
Neurol Scand. 2011 Dec;124(6):390-5. doi: 10.1111/j.1600-0404.2011.01512.x. Epub 2011 Mar 24. PubMed
PMID: 21428968.
Pallanti S, Grassi G, Sarrecchia ED, Cantisani A, Pellegrini M. Obsessive-compulsive disorder comorbidity:
clinical assessment and therapeutic implications. Front Psychiatry. 2011;2:70. Epub 2011 Dec 21. PubMed
PMID: 22203806; PubMed Central PMCID: PMC3243905.
Baldwin DS, Allgulander C, Bandelow B, Ferre F, Pallanti S. An international survey of reported prescribing
practice in the treatment of patients with generalised anxiety disorder. World J Biol Psychiatry. 2011 Nov 7.
[Epub ahead of print] PubMed PMID: 22059936.
Bernardi S, Faraone SV, Cortese S, Kerridge BT, Pallanti S, Wang S, Blanco C. The lifetime impact of
attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and
Related Conditions (NESARC). Psychol Med. 2011 Aug 16:1-13. [Epub ahead of print] PubMed PMID:
21846424.
4
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
Moretti S, Arunachalam M, Colucci R, Pallanti S, Kline JA, Berti S, Lotti F, Lotti T. Autoimmune markers in
vitiligo patients appear correlated with obsession and phobia. J Eur Acad Dermatol Venereol. 2011 Jul 1. doi:
10.1111/j.1468-3083.2011.04171.x. [Epub ahead of print] PubMed PMID: 21718366.
Di Rollo A, Pallanti S. Phantom limb pain: low frequency repetitive transcranial magnetic stimulation in
unaffected hemisphere. Case Report Med. 2011;2011:130751. Epub 2011 May 11. PubMed PMID:
21629848; PubMed Central PMCID: PMC3099190.
Berlin HA, Koran LM, Jenike MA, Shapira NA, Chaplin W, Pallanti S, Hollander E. Double-blind, placebocontrolled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder. J Clin
Psychiatry. 2011 May;72(5):716-21. Epub 2010 Aug 10. PubMed PMID: 20816027.
Pallanti S. Unique contributions of brain stimulation to the study of consciousness: where neuroscience
meets philosophy. CNS Spectr. 2010 Mar;15(3):154-6. PMID: 20414164
Pallanti S, Bernardi S, Allen A, Hollander E. Serotonin function in pathological gambling: blunted growth
hormone response to sumatriptan. J Psychopharmacol. 2010 Dec;24(12):1802-9. doi:
10.1177/0269881109106907. Epub 2009 Oct 13. PMID: 19825906
Pallanti S. Augmentation strategies in resistant obsessive-compulsive disorders (OCD), International Journal
of Psychiatry in Clinical Practice 14, 15-16, 2010-11-01.
Cincotta M., Borgheresi A., Pampaloni I., Giovannelli F., Bernardi S., Cantisani A., Zaccara G., Pallanti S.
P27-7 Motor conrtex excitability correlates with novelty neeking in social anxiety: a trascranial magnetic
stimulation study. Clinical Neurophysiology 121, s265, 2010-20-31.
Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Bruguà M, Carpentier PJ, Edvinsson D, Fayyad J, Foeken
K, Fitzgerald M, Gaillac V, Ginsberg Y, Henry C, Krause J, Lensing MB, Manor I, Niederhofer H, NunesFilipe C, Ohlmeier MD, Oswald P, Pallanti S, Pehlivanidis A, Ramos-Quiroga JA, Rastam M, Ryffel-Rawak
D, Stes S, Asherson P. European consensus statement on diagnosis and treatment of adult ADHD: The
European Network Adult ADHD. BMC Psychiatry. 2010 Sep 3;10:67. Review. PubMed PMID: 20815868;
PubMed Central PMCID: PMC2942810.
Pallanti S, Borgheresi A, Pampaloni I, Giovannelli F, Bernardi S, Cantisani A, Zaccara G, Cincotta M. Motor
cortex excitability correlates with novelty seeking in social anxiety: a transcranial magnetic stimulation
investigation. J Neurol. 2010 Aug;257(8):1362-8. Epub 2010 Mar 30. PubMed PMID: 20352252.
Bernardi S, Pallanti S. Successful duloxetine treatment of a binge eating disorder: a case report. J
Psychopharmacol. 2010 Aug;24(8):1269-72. Epub 2008 Nov 14. PubMed PMID: 19010975.
Pallanti S, Bernardi S, Allen A, Chaplin W, Watner D, DeCaria CM, Hollander E. Noradrenergic function in
pathological gambling: blunted growth hormone response to clonidine. J Psychopharmacol. 2010
Jun;24(6):847-53. Epub 2008 Nov 21. PubMed PMID: 19028836.
5
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
Bernardi S, Cortese S, Solanto M, Hollander E, Pallanti S. Bipolar disorder and comorbid attention deficit
hyperactivity disorder. A distinct clinical phenotype? Clinical characteristics and temperamental traits. World
J Biol Psychiatry. 2010 Jun;11(4):656-66. PubMed PMID: 20353313.
Pallanti S. Problematic Internet use: is it more compulsory than rewarding or mood driven? World
Psychiatry. 2010 Jun;9(2):96-7. PubMed PMID: 20671896; PubMed Central PMCID: PMC2911087.
Pallanti S, Haznedar MM, Hollander E, Licalzi EM, Bernardi S, Newmark R, Buchsbaum MS. Basal
Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography study.
Neuropsychobiology. 2010;62(2):132-8. Epub 2010 Jun 30. PubMed PMID: 20588072.
Pallanti S., Schlaepfer T.E., Lisanby S.H. The Clinical Future of Repetitive Transcranical Magnetic
Stimulation and Depression: Separating Hope From Hype. CNS Spectr 15 (9), 554-557, 2010.
Schlaepfer TE, Lisanby SH, Pallanti S. Separating hope from hype: some ethical implications of the
development of deep brain stimulation in psychiatric research and treatment. CNS Spectr. 2010
May;15(5):285-7. PubMed PMID: 20448518.
Pallanti S. Unique contributions of brain stimulation to the study of consciousness: where neuroscience
meets philosophy. CNS Spectr. 2010 Mar;15(3):154-6. Review. PubMed PMID: 20414164.
Cecchelli C, Grassi G, Pallanti S. Aripiprazole Improves Depressive Symptoms and Immunological
Response to Antiretroviral Therapy in an HIV-Infected Subject with Resistant Depression. Case Report Med.
2010;2010:836214. Epub 2010 Mar 30. PubMed PMID: 20369069; PubMed Central PMCID: PMC2847761.
Lisanby SH, Pallanti S, Schlaepfer TE. FDA considers classification of ECT. CNS Spectr. 2009
Dec;14(12):668-70. PubMed PMID: 20394174.
Pallanti S, Bernardi S, Raglione LM, Marini P, Ammannati F, Sorbi S, Ramat S. Complex repetitive
behavior: punding after bilateral subthalamic nucleus stimulation in Parkinson's disease. Parkinsonism Relat
Disord. 2010 Jul;16(6):376-80. Epub 2010 Mar 25. PubMed PMID: 20346726.
Pallanti S, Bernardi S, Di Rollo A, Antonini S, Quercioli L. Unilateral low frequency versus sequential
bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression?
Neuroscience. 2010 May 5;167(2):323-8. Epub 2010 Feb 9. PubMed PMID: 20144692.
Pallanti S, Bernardi S, Antonini S, Singh N, Hollander E. Ondansetron augmentation in treatment-resistant
obsessive-compulsive disorder: a preliminary, single-blind, prospective study. CNS Drugs. 2009
Dec;23(12):1047-55. doi: 10.2165/11530240-000000000-00000. PubMed PMID: 19958042.
Bernardi S, Pallanti S. Internet addiction: a descriptive clinical study focusing on comorbidities and
dissociative symptoms. Compr Psychiatry. 2009 Nov-Dec;50(6):510-6. Epub 2009 Jan 20. PubMed PMID:
19840588.
6
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
Potenza MN, Koran LM, Pallanti S. The relationship between impulse-control disorders and obsessivecompulsive disorder: a current understanding and future research directions. Psychiatry Res. 2009 Nov
30;170(1):22-31. Epub 2009 Oct 6. Review. PubMed PMID: 19811840; PubMed Central PMCID:
PMC2792582.
Pallanti S, Castellini G, Chamberlain SR, Quercioli L, Zaccara G, Fineberg NA. Cognitive event-related
potentials differentiate schizophrenia with obsessive-compulsive disorder (schizo-OCD) from OCD and
schizophrenia without OC symptoms. Psychiatry Res. 2009 Nov 30;170(1):52-60. Epub 2009 Oct 2.
PubMed PMID: 19800695.
Faravelli C, Lo Sauro C, Castellini G, Ricca V, Pallanti S. Prevalence and correlates of mental disorders in a
school-survey sample. Clin Pract Epidemiol Ment Health. 2009 Nov 24;5:1-8. PubMed PMID: 20498695;
PubMed Central PMCID: PMC2858519.
Pallanti S, Bernardi S. Neurobiology of repeated transcranial magnetic stimulation in the treatment of
anxiety: a critical review. Int Clin Psychopharmacol. 2009 Jul;24(4):163-73. Review. PubMed PMID:
19455047.
Bernardi S., Ramat S., Raglione L., Marini P., Sorbi S., Ammannati F., Pallanti S. Punding after bilateral
subthalamic nucleus stimulation in Parkinson’disease. European Psychiatry 23, S350-S351, 2008-04-30.
Berlin H.A., Koran L.M., Jenike M.A., Shapira N.A., Chaplin W., Pallanti S., Hollander E. Double-blind,
placebo-controlled trial of topiramate augmentation in the treatment of obsessive-compulsive disorder.
Biological Psychiatry 63 (7), 170S-170S, 2008-04-01.
Pallanti S, Hollander E. Obsessive-compulsive disorder spectrum as a scientific "metaphor". CNS Spectr.
2008 Sep;13(9 Suppl 14):6-15. Review. PubMed PMID: 18849906.
Hollander E, Buchsbaum MS, Haznedar MM, Berenguer J, Berlin HA, Chaplin W, Goodman CR, LiCalzi
EM, Newmark R, Pallanti S. FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal,
dorsolateral and cingulated metabolism. Neuropsychobiology. 2008;58(1):37-47. Epub 2008 Sep 10.
PubMed PMID: 18781089.
Pallanti S. Brain plasticity and brain stimulation in neuropsychiatry: toward individualized medicine. CNS
Spectr. 2008 Apr;13(4):287-92. PubMed PMID: 18408647.
La Malfa G, Lassi S, Bertelli M, Pallanti S, Albertini G. Detecting attention-deficit/hyperactivity disorder
(ADHD) in adults with intellectual disability The use of Conners' Adult ADHD Rating Scales (CAARS). Res
Dev Disabil. 2008 Mar-Apr;29(2):158-64. Epub 2007 Apr 9. PubMed PMID: 17416484.
Pallanti S, Masetti S, Bernardi S, Innocenti A, Markella M, Hollander E. Obsessive compulsive disorder
comorbidity in DBA. Clin Pract Epidemiol Ment Health. 2008 Mar 10;4:6. PubMed PMID: 18331650;
PubMed Central PMCID: PMC2322982.
7
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
Pallanti S. Transcultural observations of obsessive-compulsive disorder. Am J Psychiatry. 2008
Feb;165(2):169-70. PubMed PMID: 18245183.
Pallanti S, Sandner C. Treatment of depression with selective serotonin inhibitors: the role of fluvoxamine.
Int. J. Psych. In Clinical Practice. 2007; 11(3): 233-238.Doi: 10.1080/13651500701419685
Fineberg NA, Pampaloni I, Pallanti S, Ipser J, Stein DJ. Sustained response versus relapse: the
pharmacotherapeutic goal for obsessive-compulsive disorder. Int Clin Psychopharmacol. 2007
Nov;22(6):313-22. Review. PubMed PMID: 17917549.
Hollander E, Kim S, Khanna S, Pallanti S. Obsessive-compulsive disorder and obsessive-compulsive
spectrum disorders: diagnostic and dimensional issues. CNS Spectr. 2007 Feb;12(2 Suppl 3):5-13. PubMed
PMID: 17277719.
Pallanti S., Baker B.R., Chaplin W., Kim S., De Caria C., Bernardi S., Hollander E., Noradrenergic function
in pathological gambling. BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENTIFIC INC, 59 (8), 32S-32S,
2006-04-15.
Pallanti S, Quercioli L. Resistant social anxiety disorder response to Escitalopram. Clin Pract Epidemiol
Ment Health. 2006 Dec 13;2:35. PubMed PMID: 17166264; PubMed Central PMCID: PMC1769378.
Pallanti S, Bernardi S, Quercioli L. The Shorter PROMIS Questionnaire and the Internet Addiction Scale in
the assessment of multiple addictions in a high-school population: prevalence and related disability. CNS
Spectr. 2006 Dec;11(12):966-74. PubMed PMID: 17146410.
Pallanti S, Bernardi S, Quercioli L, DeCaria C, Hollander E. Serotonin dysfunction in pathological gamblers:
increased prolactin response to oral m-CPP versus placebo. CNS Spectr. 2006 Dec;11(12):956-64. PubMed
PMID: 17146409.
Pallanti S. From impulse-control disorders toward behavioral addictions. CNS Spectr. 2006;11(12).921-922
Buchsbaum MS, Hollander E, Pallanti S, Baldini Rossi N, Platholi J, Newmark R, Bloom R, Sood E.
Positron emission tomography imaging of risperidone augmentation in serotonin reuptake inhibitorrefractory patients. Neuropsychobiology. 2006;53(3):157-68. Epub 2006 May 16. PubMed PMID: 16707915.
Pallanti S, Quercioli L. Treatment-refractory obsessive-compulsive disorder: methodological issues,
operational definitions and therapeutic lines. Prog Neuropsychopharmacol Biol Psychiatry. 2006
May;30(3):400-12. Epub 2006 Feb 28. Review. PubMed PMID: 16503369.
Rossi A, Rucci P, Mauri M, Maina G, Pieraccini F, Pallanti S, Endicott J; (For the EQUIP group). Reliability
and validity of the Italian version of the Quality of Life, Enjoyment and Satisfaction Questionnaire. Qual
Life Res. 2005 Dec;14(10):2323-8. PubMed PMID: 16328911.
8
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
Pallanti S, DeCaria CM, Grant JE, Urpe M, Hollander E. Reliability and validity of the pathological
gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). J Gambl Stud. 2005
Winter;21(4):431-43. PubMed PMID: 16311876.
Pallanti S, Lassi S, La Malfa G, Campigli M, Di Rubbo R, Paolini G, Cesarali V. Short report: Autistic
gastrointestinal and eating symptoms treated with secretin: a subtype of autism. Clin Pract Epidemiol Ment
Health. 2005 Nov 15;1:24. PubMed PMID: 16287506; PubMed Central PMCID: PMC1308834.
Hollander E, Pallanti S, Baldini Rossi N, Sood E, Baker BR, Buchsbaum MS. Imaging monetary reward in
pathological gamblers. World J Biol Psychiatry. 2005;6(2):113-20. PubMed PMID: 16156484.
Pallanti S, Lotti T, Urpe M. Psychoneuroimmunodermatology of atopic dermatitis: from empiric data to the
evolutionary hypothesis. Dermatol Clin. 2005 Oct;23(4):695-701. Review. PubMed PMID: 16112446.
Urpe M, Pallanti S, Lotti T. Psychosomatic factors in dermatology. Dermatol Clin. 2005 Oct;23(4):601-8.
Review. PubMed PMID: 16112435.
Haznedar MM, Roversi F, Pallanti S, Baldini-Rossi N, Schnur DB, Licalzi EM, Tang C, Hof PR, Hollander
E, Buchsbaum MS. Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their
connections in bipolar spectrum illnesses. Biol Psychiatry. 2005 Apr 1;57(7):733-42. PubMed PMID:
15820230.
Hollander E, Sood E, Pallanti S, Baldini-Rossi N, Baker B. Pharmacological treatments of pathological
gambling. J Gambl Stud. 2005 Spring;21(1):99-110. Review. PubMed PMID: 15789195.
Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N. Does sustained-release lithium reduce impulsive
gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
Am J Psychiatry. 2005 Jan;162(1):137-45. PubMed PMID: 15625212.
Pallanti S. Review of perfectionism: theory, research and treatment. American Journal, 2004, vol.161 (8),
ISSN: 0092-119X
Pallanti S, Hollander E, Goodman WK. A qualitative analysis of nonresponse: management of treatmentrefractory obsessive-compulsive disorder. J Clin Psychiatry. 2004;65 Suppl 14:6-10. Review. PubMed
PMID: 15554782.
Pallanti S, Quercioli L, Bruscoli M. Response acceleration with mirtazapine augmentation of citalopram in
obsessive-compulsive disorder patients without comorbid depression: a pilot study. J Clin Psychiatry. 2004
Oct;65(10):1394-9. PubMed PMID: 15491244.
9
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
Quercioli L., Bruscoli M., Pallanti S. P.1.030 Mirtazapine augmentation of citalopram response in OCD
patients without comorbid depression: A pilot study. European Neuropsychopharmacology 14, S186, 200410-31.
Pallanti S, Quercioli L, Hollander E. Social anxiety in outpatients with schizophrenia: a relevant cause of
disability. Am J Psychiatry. 2004 Jan;161(1):53-8. PubMed PMID: 14702250.
Hollander E, Baldini Rossi N, Sood E, Pallanti S. Risperidone augmentation in treatment-resistant obsessivecompulsive disorder: a double-blind, placebo-controlled study. Int J Neuropsychopharmacol. 2003
Dec;6(4):397-401. PubMed PMID: 14604454.
Sood ED, Pallanti S, Hollander E. Diagnosis and treatment of pathologic gambling. Curr Psychiatry Rep.
2003 May;5(1):9-15. Review. PubMed PMID: 12685996.
Buchbaum M.S., Hollander E., Pallanti S., Baldini-Rossi N. Brikman A.M., Platholi J., Sood E. Positron
emission tomography. Imaging of risperidone augmentation in SRI-refrectory patients. BIOLOGICAL
PSYCHIATRY 51 (8), 47S-47S, 2002-04-14
Sood E, Pallanti S, Hollander E. Serotonin reuptake inhibitors in the treatment of pathological gambling.
Essential Psychopharmacology. 2002 vol 5 (3), p.157-169, ISSN: 1087-495X
Pallanti S, Baldini Rossi N, Sood E, Hollander E. Nefazodone treatment of pathological gambling: a
prospective open-label controlled trial. J Clin Psychiatry. 2002 Nov;63(11):1034-9. PubMed PMID:
12444818.
Pallanti S, Quercioli L, Koran LM. Citalopram intravenous infusion in resistant obsessive-compulsive
disorder: an open trial. J Clin Psychiatry. 2002 Sep;63(9):796-801. PubMed PMID: 12363120.
Pallanti S, Quercioli L, Sood E, Hollander E. Lithium and valproate treatment of pathological gambling: a
randomized single-blind study. J Clin Psychiatry. 2002 Jul;63(7):559-64. PubMed PMID: 12143910.
Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D, Pato M, Stein D, Zohar J;
International Treatment Refractory OCD Consortium. Treatment non-response in OCD: methodological
issues and operational definitions. Int J Neuropsychopharmacol. 2002 Jun;5(2):181-91. Review. PubMed
PMID: 12135542.
Hollander E, Bienstock CA, Koran LM, Pallanti S, Marazziti D, Rasmussen SA, Ravizza L, Benkelfat C,
Saxena S, Greenberg BD, Sasson Y, Zohar J. Refractory obsessive-compulsive disorder: state-of-the-art
treatment. J Clin Psychiatry. 2002;63 Suppl 6:20-9. Review. PubMed PMID: 12027116.
Presta S, Marazziti D, Dell'Osso L, Pfanner C, Pallanti S, Cassano GB. Kleptomania: clinical features and
comorbidity in an Italian sample. Compr Psychiatry. 2002 Jan-Feb;43(1):7-12. PubMed PMID: 11788913.
10
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
Ramacciotti A, Sorbello M, Pazzagli A, Vismara L, Mancone A, Pallanti S. Attachment processes in eating
disorders. Eat Weight Disord. 2001 Sep;6(3):166-70. PubMed PMID: 11589419.
Pallanti S., Quercioli L. Alternative route of administration and titration of SRIs in anxious resistant
patients:Two day-hospital experiences. European Neuropsychopharmacology 11, S312, 2001-12-31.
Pallanti S. Panic Disorder: Clinical Diagnosis, Management and Mechanism. American Journal of Psychiatry
158(7), 1176-a-1177. 2001-07-01.
Hollander E., Bienstock C.A., Koran L.M., Pallanti S., Marazzini D., Rasmussen S.A., Ravizza L., Benkelfat
C., saxena S., Greenberg D.B., Sasson Y., Zohar J. Refractory obsessive-compulsive disorder: state-of-the-art
treatment. The Jornal of clinical psychiatry 63, 20-29, 12-2001.
Hollander E, Pallanti S. 5-HT(1D) function and repetitive behaviors. Am J Psychiatry. 2001 Jun;158(6):9723. PubMed PMID: 11384926.
Koran LM, Pallanti S, Quercioli L. Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder. Eur
Neuropsychopharmacol. 2001 Apr;11(2):169-72. PubMed PMID: 11313163.
Pallanti S., Quercioli L. Reboxetine in bulimia nervosa: An open study. BIOLOGICAL PSYCHIATRY 49
(8), 105S-106S. 2001-04-05.
Rossi A, Arduini L, Stratta P, Pallanti S. Subjective experience and subjective response to neuroleptics in
schizophrenia. Compr Psychiatry. 2000 Nov-Dec;41(6):446-9. PubMed PMID: 11086150.
Pallanti S., Quercioli L. SSRIs in the treatment of premenstrual dysphoric disorder. Nefazodone: An open
trial. European Neuropsychopharmacology 10, 127-127, 2000-09-30.
Pallanti S. The anxiety-psychosis spectrum. CNS Spectr. 2000 Sep;5(9):22. PubMed PMID: 17637576.
Pallanti S, Quercioli L, Pazzagli A. Social anxiety and premorbid personality disorders in paranoid
schizophrenic patients treated with clozapine. CNS Spectr. 2000 Sep;5(9):29-43. PubMed PMID: 17637578.
Pallanti S, Quercioli L. Shame and psychopathology. CNS Spectr. 2000 Aug;5(8):28-43. PubMed PMID:
18192938.
Pallanti S. Dr. Pallanti Replies. American Jornal of Psychiatry 157 (5), 840-a-840. 2000-05-01.
11
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
Di Russo F, Zaccara G, Ragazzoni A, Pallanti S. Abnormal visual event-related potentials in obsessivecompulsive disorder without panic disorder or depression comorbidity. J Psychiatr Res. 2000 JanFeb;34(1):75-82. PubMed PMID: 10696834.
Pallanti S. Obsessive-Compulsive Disorder: Theory, Research, and Treatment. Am J Psychiatry
1999;156:1108a-1109. ISSN: 0092-119X
Pallanti S, Quercioli L, Rossi A, Pazzagli A. The emergence of social phobia during clozapine treatment and
its response to fluoxetine augmentation. J Clin Psychiatry. 1999 Dec;60(12):819-23. PubMed PMID:
10665627.
Marazziti D, Pallanti S. Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder. Am
J Psychiatry. 1999 Nov;156(11):1834-5. PubMed PMID: 10553756.
Pini S, Dell'Osso L, Mastrocinque C, Marcacci G, Papasogli A, Vignoli S, Pallanti S, Cassano G. Axis I
comorbidity in bipolar disorder with psychotic features. Br J Psychiatry. 1999 Nov;175:467-71. PubMed
PMID: 10789280.
Pallanti S, Quercioli L, Pazzagli A. Basic symptoms and P300 abnormalities in young schizophrenic patients.
Compr Psychiatry. 1999 Sep-Oct;40(5):363-71. PubMed PMID: 10509619.
Pallanti S, Quercioli L, Paiva RS, Koran LM. Citalopram for treatment-resistant obsessive-compulsive
disorder. Eur Psychiatry. 1999 Apr;14(2):101-6. PubMed PMID: 10572334.
Pallanti S, Quercioli L, Pazzagli A, Rossi A, Dell'Osso L, Pini S, Cassano GB. Awareness of illness and
subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder. Am J
Psychiatry. 1999 Jul;156(7):1094-6. PubMed PMID: 10401459.
Pallanti S, Quercioli L, Pazzagli A. Effects of clozapine on awareness of illness and cognition in
schizophrenia. Psychiatry Res. 1999 Jun 30;86(3):239-49. PubMed PMID: 10482343.
Pallanti S, Koran LM. Citalopram and sexual side effects of selective serotonin reuptake inhibitors. Am J
Psychiatry. 1999 May;156(5):796. PubMed PMID: 10327919.
Pallanti S. Ugo Cerletti. 1877-1963 Essay. American Jornal of Psychiatry 156.630-630, 1999.
Russo F., Zaccara G., Ragazzoni A. Pallanti S. Abnormal visual ERPs in ossessive-compulsive deficits in
young schizophrenic patients. Jornal of Psychophysiology 13 (3), 207-207, 1999-01-01.
Pallanti S., Quercioli L. Objective and subjective investigation of cognitive deficicts in young schizophrenic
patients. Jornal of Psychophysiology 13 (3), 203-203, 1999-01-01.
12
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
Pallanti S. IMAGES IN PSYCHIATRY. American Journal of Psychiatry 156 (4), 630, 1999.
Sallee FR, Koran LM, Pallanti S, Carson SW, Sethuraman G. Intravenous clomipramine challenge in
obsessive-compulsive disorder: predicting response to oral therapy at eight weeks. Biol Psychiatry. 1998 Aug
1;44(3):220-7. PubMed PMID: 9693393.
Koran LM, Pallanti S, Paiva RS, Quercioli L. Pulse loading versus gradual dosing of intravenous
clomipramine in obsessive-compulsive disorder. Eur Neuropsychopharmacol. 1998 May;8(2):121-6.
PubMed PMID: 9619690.
Pallanti S, Quercioli L, Zaccara G, Ramacciotti AB, Arnetoli G. Eye movement abnormalities in anorexia
nervosa. Psychiatry Res. 1998 Mar 20;78(1-2):59-70. PubMed PMID: 9579703.
Pallanti S, Quercioli L, Ramacciotti A. Citalopram in anorexia nervosa. Eat Weight Disord. 1997
Dec;2(4):216-21. PubMed PMID: 14655831.
Inzitari D, Pantoni L, Lamassa M, Pallanti S, Pracucci G, Marini P. Emotional arousal and phobia in transient
global amnesia. Arch Neurol. 1997 Jul;54(7):866-73. PubMed PMID: 9236576.
Ramacciotti A, Pallanti S, Pazzagli A. A setting including psychotherapy and psychopharmacological
treatment in a case of anorexia nervosa with obsessive compulsive disorder comorbidity. Eat Weight Disord.
1997 Dec;2(4):222-8. PubMed PMID: 14655832.
Di Russo F., Zaccara G., Pallanti S., Gangemi P., Lori S., Ragazzoni A. Visual event-related potentials in
obsessive-compulsive disorders. Electroencephalography and Clinical Neurophysiology 103 (1), 211-211,
Jul 1997.
Pallanti S, Quercioli L, Pazzagli A. Relapse in young paranoid schizophrenic patients: a prospective study of
stressful life events, P300 measures, and coping. Am J Psychiatry. 1997 Jun;154(6):792-8. PubMed PMID:
9167506.
Koran LM, Sallee FR, Pallanti S. Rapid benefit of intravenous pulse loading of clomipramine in obsessivecompulsive disorder. Am J Psychiatry. 1997 Mar;154(3):396-401. PubMed PMID: 9054789.
Pallanti S. Personality Disorders: Myths and Neuroscience. CNS Spectrum 2, 53-63, 1997.
Bersani G., Saito A. Pallanti S. Sasso E., Tosca P. Clinical variables and response to citalopram in Major
Depression: an open multicentric study. Rivista di Psichiatria 32, 260-267, 1997.
Pallanti S, Koran LM. two case report. CNS Spectrums 1996, vol.1, p.54-57, ISSN: 1092-8529
13
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
Pallanti S, Grecu LM, Gangemi PF, Massi S, Parigi A, Arnetoli G, Quercioli L, Zaccara G. Smooth-pursuit
eye movement and saccadic intrusions in obsessive-compulsive disorder. Biol Psychiatry. 1996 Dec
1;40(11):1164-72. PubMed PMID: 8931920.
Koran L., Sallee F., Pallanti S., Paiva R., Quercioli L. Intravenous pilse loading of clomipramine in
obsessive-compulsive disorder. Psychopharmacology Bulletin 32 (3), 466-466. Nov. 1996.
Pallanti S. Vincenzo Chiarugi, 1759-1820. Am J Psychiatry. 1996 Jul;153(7):944. PubMed PMID: 8659619.
Grassi E, Mortilla M, Amaducci L, Pallanti S, Pazzagli A, Galassi F, Guarnieri BM, Petruzzi C, Bolino F,
Ortenzi L, Nistico R, De Cataldo S, Rossi A, Sorbi S. No evidence of linkage between schizophrenia and D2
dopamine receptor gene locus in Italian pedigrees. Neurosci Lett. 1996 Mar 15;206(2-3):196-8. PubMed
PMID: 8710185.
Koran LM, Faravelli C, Pallanti S. Intravenous clomipramine for obsessive-compulsive disorder. J Clin
Psychopharmacol. 1994 Jun;14(3):216-8. PubMed PMID: 8027426.
Pallanti S., Zuccarini S., Rivelli A., Quercioli L., Pazzagli A. Depth perception in schizophreni. Biological
Psychiatry 35 (9), 637-638. 1994-05-01.
Mortilla M, Amaducci L, Bruni A, Montesi MP, Trubnikov A, De Cataldo S, Pallanti S, Pazzagli A, Grecu L,
Servi P, et al. Absence of APP713 mutation in Italian and Russian families with schizophrenia. Neurosci Lett.
1994 Jan 3;165(1-2):45-7. PubMed PMID:
8015735.
Faravelli C., Pallanti S., Biondi F., Paterniti S., Scarpato M.A. Assessment of onset of panic disorder in
relatrion to onset of agoraphobia-replay. American Journal of Psychiatry 150 (9), 1437-1437. 1993-09-01.
Faravelli C., Pallanti S., Biondi F., Paterniti S., Scarpato M.A. Dr. Faravelli and Associaties Replay.
American Journal of Psychiatry 150 (9), 1437-1437. 1993-09-01.
Pallanti S., Rossi L., De Palma G., Checchi M., Muscas C., Faravelli C. Electroencephalogram mapping in
sodium lactate-induced panic attacks: Preliminary results. Imaging of the Brain in Psychiatry and Related
Fields, 281-284. 1993-01-01.
Pallanti S., Pavia R.S. A demencia emu ma prospectiva psico (pato) lògica. J. Bras. Psiquiatr 41 (9), 447-50.
Ott. 1992.
Faravelli C., Pallanti S., Strik W.K. Stress load and schizophrenic disorder. Der Nervenarzt 59 (4), 237-239.
Apr. 1988.
14
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
Faravelli C., Pallanti S., Frassine R., Guerrini B., Albanesi G., Early events as predisposing factors. Anxious
depression: assessment and treatment, 49, 1997.
M.Weissman, L.Bobins, J.Escobar, R.Bland, G.Canino, H.Wittchen, C.Faravelli, S.Pallanti, J.Lepine,
P.Pariente, E.Karam, J.Wells, H.Hwu, G.Klerman, P.Lavori, W.Maier (1992). The changing rate of
depression. JAMA, vol. 268, p. 3098-3105, ISSN: 0098-7484
Zaccara G, Gangemi PF, Muscas GC, Paganini M, Pallanti S, Parigi A, Messori A, Arnetoli G. Smoothpursuit eye movements: alterations in Alzheimer's disease. J Neurol Sci. 1992 Oct;112(1-2):81-9. PubMed
PMID: 1469444.
Pallanti S, Mazzi D. MDMA (Ecstasy) precipitation of panic disorder. Biol Psychiatry. 1992 Jul 1;32(1):915. PubMed PMID: 1356491.
Faravelli C, Pallanti S, Biondi F, Paterniti S, Scarpato MA. Onset of panic disorder. Am J Psychiatry. 1992
Jun;149(6):827-8. PubMed PMID: 1590502.
Faravelli C, Panichi C, Pallanti S, Paterniti S, Grecu LM, Rivelli S. Perception of early parenting in panic
and agoraphobia. Acta Psychiatr Scand. 1991 Jul;84(1):6-8. PubMed PMID: 1927567.
Faravelli C, Guerrini Degl'Innocenti B, Aiazzi L, Incerpi G, Pallanti S. Epidemiology of mood disorders: a
community survey in Florence. J Affect Disord. 1990 Oct;20(2):135-41. PubMed PMID: 2148328.
Smeraldi E., Orsini A., Gasperini M., Sciuto G., Battaglia M., Cassano G.B., Perugi G., Faravelli C., Pallanti
S, Bressa G. Familial analysis of panic disorder and agoraphobia. Journal of Affective Disorders, 1989,
vol.17, p.1-8. ISSN: 0165-0327
Faravelli C, Pallanti S. Recent life events and panic disorder. Am J Psychiatry. 1989 May;146(5):622-6.
PubMed PMID: 2712167.
Faravelli C, Pallanti S, Strik WK. [Stress load and schizophrenic disorder]. Nervenarzt. 1988 Apr;59(4):2379. German. PubMed PMID: 3386773.
Faravelli C, Pallanti S, Frassine R, Albanesi G, Guerrini Degl'Innocenti B. Panic attacks with and without
agoraphobia: a comparison. Psychopathology. 1988;21(1):51-6. PubMed PMID: 3222433.
Faravelli C, Pallanti S. Clomipramine by different routes of administration: short- and long-term efficacy and
predictors of clinical outcome. Psychopharmacol Bull. 1987;23(3):459-63. PubMed PMID: 3432514.
15
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
Faravelli C, Ambonetti A, Pallanti S, Pazzagli A. Depressive relapses and incomplete recovery from index
episode. Am J Psychiatry. 1986 Jul;143(7):888-91. PubMed PMID: 3717430.
Pallanti S., Rossi N.B., Friedberg J., Hollander E. Psychobiology of Impulse-Control Disorders Not
Otherwise Specified (NOS). Biologiccal Psychiatry, 1315-1329.
Faravelli C, Sacchetti E, Ambonetti A, Conte G, Pallanti S, Vita A. Recent life events and affective disorder
revisited. Br J Psychiatry. 1986 Mar;148:288-95. PubMed PMID: 3719221.
BOOKS
1. Pallanti, S., Oltre la Schizophrenia (Beyond Schizophrenia) Elsevier, in press
2. Pallanti, S. and Lauriello, J., Edit., Clinical Manual for Treatment of Schizophrenia, American
Psychiatric Pub. (2011)
3. Pallanti, S. and Formosa, A., Stress? No grazie, siamo resiliente, Trevisini Editore. (2011)
4. Pallanti, S. and Lauriello, J., Clinical Manual for Schizophrenia, Edited by B. Hales, American
Psychiatric Pub. (2010)
5. Fossi G., Pallanti S., Psichiatria Elementare (Elementary Psychiatry), La Nuova Italia
S.p.A. Roma. First edition 1993, 6th edition 2008
Scientifica
6. Pallanti S., Bruscoli M., Le Emergenze Psichiatriche in Medicina , Lippincott /Williams and
Wilkins, (2006) sold exclusively by Innova Pharma SpA, Milano
7. Pallanti S., Koran L. M., Treatment of OCD Resistant Patients, Airon (2003)
8. Fossi G., Pallanti S., Manuale di Psichiatria (Manual of Psychiatry), Casa Editrice Ambrosiana,
Milano (1993)
9. Pallanti S., Vivere con le Voci, Vivere nel Silenzio, La nuova Italia Scientifica (1996)
CHAPTERS IN BOOKS
1.
Pathological Gambling, pp 251 – 289, Clinical Manual of Impulse Control Disorders, Edited by E.
Hollander, D. Stein, American Psychiatric Pub., 2006
2.
Pharmacological Treatments, pp 189 – 200, Pathological Gambling : A Clinical Guide to
Treatment, Edited by J. E. Grant, M. Potenza, American Psychiatric Pub., 2004
3.
Current and Experimental Therapeutics of Obsessive Compulsive Disorders, pp 1647 – 1664,
Neuropsychopharmacology : The Fifth Generation of Progress, An Official Publication of the
American College of Neuropsychopharmacology, Edited by K.L. Davis, D. Charney, J.T. Coyle and
C. Nemeroff, Lippincott/Williams and Wilkins, 2002
4.
Psychobiology of Impulse Control Disorders Not Otherwise Specified (NOS), pp 1315 – 1329,
Biological Psychiatry, Edited by H. D’Haenen, J.A. den Boer, P. Willner, John Wiley
& Sons Ltd., 2002
16
Stefano Pallanti M.D. PhD
total 17 pages, as of 6 November 2015
EDITORIAL ACTIVITIES
American Psychiatric Publishing: Editor since 2008
American Journal of Psychiatry: Reviewer
American Journal of Psychiatry Italian edition: Editor in Chief since 2008
Archives of General Psychiatry: Reviewer
Biological Psychiatry: Reviewer
Brain Imaging and Behavior: Reviewer
CNS Spectrums – International Journal of Neuropsychiatric Medicine:
Member of the Advisory Board.
Bimonthly columnist.
Guest editor in 2000 and 2006
Eating and Weight Disorders: Member of the Editorial Board
European Neurophychopharmacology: Reviewer
Frontier: Member of Editorial Committee
Giornale Italiano di Psicopatologia: Member of the Board
International Journal of Psychiatry in Clinical Practice: Editorial board member and Reviewer
Journal of Addiction and Therapy: Editorial Board member
Journal of Clinical Psychiatry: Reviewer
Journal of Gambling Studies: Member of the Editorial Board
Journal of Psychiatric Research: Reviewer
Lancet: Reviewer
Progress in Neuro-Psychopharmacology & Biological Psychiatry: Reviewer
Psychiatry Research: Reviewer
17